Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 3
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Distinguishing Classical Hodgkin Lymphoma, Gray Zone Lymphoma, and Large B-cell Lymphoma: A Proposed Scoring System.
O'Malley DP, Fedoriw Y, Weiss LM. O'Malley DP, et al. Appl Immunohistochem Mol Morphol. 2016 Sep;24(8):535-40. doi: 10.1097/PAI.0000000000000236. Appl Immunohistochem Mol Morphol. 2016. PMID: 26447896 Review.
BACKGROUND: The diagnosis of "B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma" represents an indeterminate or equiv …
BACKGROUND: The diagnosis of "B-cell lymphoma, unclassifiable, with features intermediate between …
Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A case report.
Shi F, Zhou Q, Gao Y, Cui XQ, Chang H. Shi F, et al. Oncol Lett. 2016 Sep;12(3):1925-1928. doi: 10.3892/ol.2016.4840. Epub 2016 Jul 11. Oncol Lett. 2016. PMID: 27602118 Free PMC article.
B-cell lymphoma (BCL), unclassifiable, with features intermediate between diffuse large BCL (DLBCL) and classical Hodgkin's lymphoma (CHL), is a novel entity to the World Health Organization classification system. ... …
B-cell lymphoma (BCL), unclassifiable, with features intermediate between diffuse large …
B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and classical hodgkin lymphoma: diagnosis by fine-needle aspiration cytology.
Lynnhtun K, Varikatt W, Pathmanathan N. Lynnhtun K, et al. Diagn Cytopathol. 2014 Aug;42(8):690-3. doi: 10.1002/dc.22967. Epub 2013 Apr 30. Diagn Cytopathol. 2014. PMID: 23630122
A broad panel of immunocytochemical stains performed on the cell block was indicative of a lymphoproliferative disorder, but the immunophenotype was intermediate between diffuse large B cell lymphoma (DLBCL) and classical Hodgkin lymph …
A broad panel of immunocytochemical stains performed on the cell block was indicative of a lymphoproliferative disorder, but the immunopheno …
J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM, Swerdlow SH, Gibson SE. Moore EM, et al. Hum Pathol. 2017 Oct;68:47-53. doi: 10.1016/j.humpath.2017.08.015. Epub 2017 Aug 26. Hum Pathol. 2017. PMID: 28851661
We investigated the utility of J chain and myocyte enhancer factor 2B (MEF2B) in the diagnosis of CHL; NLPHL; PMBL; T-cell/histiocyte-rich large B-cell lymphoma (TCRLBL); and B-cell lymphoma, unclassifiable, with features …
We investigated the utility of J chain and myocyte enhancer factor 2B (MEF2B) in the diagnosis of CHL; NLPHL; PMBL; T-cell/histiocyte-rich …